Use access key #2 to skip to page content.
$11.62 -0.05 (-0.43%)
10/10/2008 4:00 PM

Omrix Biopharmaceuticals, Inc. (OMRI)

CAPS Rating:
*****

A commercial-stage biopharmaceutical company that develops and markets innovative biological products.

View Ticker Page (OMRI)

Results 21 - 30 of 58 :   12345Next »

Recs

0

Avatar JohnnyiPhone (< 20) Submitted: 6/13/08 8:27 AM : Outperform Start Price: $17.08 OMRI Score: 2.23

Member of the "Mini-Cap Monsters."

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar notzia (< 20) Submitted: 6/06/08 10:09 AM : Outperform Start Price: $16.95 OMRI Score: 4.77

The chart looked good, the product line looked good to me, there are recent insider purchases, and the way Johnson and Johnson are treating this company (as compared to other supply partners) all speak to a strong financial story. I do own this stoc...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar ResearchLover (< 20) Submitted: 5/15/08 2:36 PM : Outperform Start Price: $15.33 OMRI Score: 13.36

Looks like analysts give it a price target in the 20s, and growth projections are up, though fluctuating. Profit margin looks good. I actually have owned competitor KG since december 2007, but that is a defensive position, whereas this is one with ...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar DavidBear (30.37) Submitted: 5/14/08 9:25 AM : Outperform Start Price: $14.40 OMRI Score: 17.93

Insider buying, depressed price, PEG of 0.7.
What is not to like?

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar YoungInvestor99 (76.27) Submitted: 5/06/08 8:07 PM : Outperform Start Price: $14.70 OMRI Score: 16.71

RuleBreaker Pick

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar sunnybrasil (81.59) Submitted: 4/05/08 8:33 PM : Outperform Start Price: $15.85 OMRI Score: 9.14

The company has reached a reasonable P/E rating and is a speculitive buy.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar ennui (64.73) Submitted: 4/01/08 8:08 AM : Outperform Start Price: $14.00 OMRI Score: 16.80

Biotech company specializing in blood plasma products. Stock has been pummeled, and insiders are buying. I could see this as a buy-out candidate for their partner, J&J. Profitable company, reasonable PE, great growth opportunities. As often happens, ...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar cold5starstocks (21.83) Submitted: 3/31/08 10:36 PM : Outperform Start Price: $14.00 OMRI Score: 16.80

Experiment time... I will pick whatever stocks that are on the cold 5 star list on the last trading day of each month. There is no research involved other what is on the cold 5 star list at the end of each month. Each pick will be for one year. Lets ...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar showtime33 (< 20) Submitted: 4/02/08 8:53 PM : Outperform Start Price: $13.32 OMRI Score: 19.83

up

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar dpschultz (< 20) Submitted: 3/29/08 12:59 AM : Outperform Start Price: $13.32 OMRI Score: 19.83

Good buy, small cap, large promising portfolio, P/E around 20

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners